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Background
The functional HIV-1 Env exists on the surface of infec-
tious virions as a non-covalently associated trimer of het-
erodimers (gp120 and gp41). The protomers of the trimer
are identical in composition and glycosylation and form a
structure on which conserved neutralization epitopes are
not readily exposed and are poorly immunogenic. We are
investigating the possibility that conserved neutralization
epitopes are less occluded and are more immunogenic on
trimers that are composed of distinct protomers. We engi-
neered, expressed and purified stable heterotrimers
formed from Envs derived from SF162 (clade B primary
isolate) and four clade A primary isolates (Q168a2,
Q259d17, Q461e2 & Q769h5) and determined their anti-
genic and immunogenic properties.
Methods
Heterotrimeric gp140s were produced by transient trans-
fection and purified using affinity, tag-based and size
exclusion chromatography. Epitope exposure was deter-
mined by ELISA using mAbs. Rabbits were immunized
with heterotrimeric Env SF162gp140His/
Q461e2gp140FLAG) or with a mixture of the correspond-
ing homotrimers, using PEI as an adjuvant. Antibody tit-
ers were determined using ELISA and Luminex.
Results
The CD4-binding site (and potentially the MPER) is better
exposed on the heterotrimer compared to the correspond-
ing homotrimers. Anti-Env antibody titers were elicited by
both the heterotimer and mixed homotrimers, but dis-
tinct epitope specificities were evident. The heterotrimer
elicited high titers of anti-4E10 antibodies, while such
antibodies were not elicited by the corresponding mix of
homotrimers. All animals immunized with the heterot-
rimer also elicited anti-2F5 antibodies. Thus, it appears
that the MPER is highly immunogenic on the clade A/B
heterotrimer.
Conclusion
The exposure and immunogenicity of specific epitopes
differs between the gp140 heterotrimer and mixed homo-
trimers. The fact that the heterotrimer elicited high titers
of anti-4E10 and anti-2F5 antibodies suggests that such
constructs could be optimized to elicit neutralizing anti-
bodies against these conserved neutralization epitopes.
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